Target Name: INO80D
NCBI ID: G54891
Review Report on INO80D Target / Biomarker Content of Review Report on INO80D Target / Biomarker
INO80D
Other Name(s): IN80D_HUMAN | INO80 complex subunit D

INO80D: A Potential Drug Target Or Biomarker

INO80D (IN80D_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and muscle. It is a member of the superfamily of untranscribed spliced proteins (USP), which are a class of non-coding RNAs that can be processed by the splicing machinery to generate functional proteins.

INO80D is characterized by its unique molecular structure, which consists of a single exon that is excluded from the final protein product by splicing. This unique feature has led to significant interest in INO80D as a potential drug target or biomarker.

One of the key advantages of INO80D is its ability to be targeted by small molecules. This is because the protein is expressed in a wide range of tissues and cells, which makes it relatively accessible for drug developers to study its effects. Additionally, because INO80D is a spliced protein, it is possible to alter its expression levels by changing the amount of introns or exons that are included in the final product. This allows researchers to study the effects of different drug molecules on the levels of INO80D in different tissues and cells.

Another potential advantage of INO80D is its role in various biological processes. INO80D has been shown to be involved in a number of important biological processes, including cell signaling, DNA replication, and metabolism. For example, INO80D has been shown to be involved in the regulation of cell growth and differentiation, as well as in the process of DNA replication. Additionally, INO80D has been shown to play a role in the metabolism of fats and carbohydrates, which is important for maintaining energy homeostasis in the body.

Despite the potential benefits of INO80D as a drug target or biomarker, there are also concerns about its potential drawbacks. For example, because INO80D is expressed in a wide range of tissues and cells, it is possible that it could be involved in a number of different biological processes, which could make it difficult to study its effects in isolation. Additionally, because INO80D is a spliced protein, it is possible that different cell types may express different variants of the protein, which could affect its effects.

Overall, INO80D is a protein that has significant potential as a drug target or biomarker. Its unique molecular structure and ability to be targeted by small molecules make it an attractive target for drug developers. Additionally, its involvement in various important biological processes makes it a valuable tool for studying the effects of different drugs in different tissues and cells.

Protein Name: INO80 Complex Subunit D

Functions: Putative regulatory component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair

The "INO80D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about INO80D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

INO80E | Inositol 1,4,5-Trisphosphate Receptor (InsP3R) | Inositol hexakisphosphate kinase | Inositol Monophosphatase | INPP1 | INPP4A | INPP4B | INPP5A | INPP5B | INPP5D | INPP5E | INPP5F | INPP5J | INPP5K | INPPL1 | INS | INS-IGF2 | INSC | INSIG1 | INSIG2 | INSL3 | INSL4 | INSL5 | INSL6 | INSM1 | INSM2 | INSR | INSRR | Insulin-like growth factor | Insulin-like growth factor 2 mRNA binding protein | Insulin-like growth factor 2 mRNA-binding protein 1 (isoform 2) | Insulin-like growth factor-binding protein | INSYN1 | INSYN2A | INSYN2B | Integrator complex | Integrin alpha1beta1 (VLA-1) receptor | Integrin alpha2beta1 (VLA-2) receptor | Integrin alpha2beta3 Receptor | Integrin alpha3beta1 receptor | Integrin alpha4beta1 (VLA-4) receptor | Integrin alpha4beta7 (LPAM-1) receptor | Integrin alpha5beta1 (VLA-5) receptor | Integrin alpha5beta3 receptor | Integrin alpha6beta1 Receptor | Integrin alpha6beta4 receptor | Integrin alpha7beta1 Receptor | Integrin alpha9beta1 receptor | Integrin alphaEbeta7 receptor | Integrin alphaLbeta2 (LFA-1) receptor | Integrin alphaMbeta2 (MAC-1) Receptor | Integrin alphavbeta1 | Integrin alphavbeta3 (vitronectin) receptor | Integrin alphavbeta5 receptor | Integrin alphavbeta6 receptor | Integrin alphavbeta8 Receptor | Integrin Receptor | Integrin-linked kinase | Interferon | Interferon-alpha (IFN-alpha) | Interferon-gamma Receptor | Interleukin 17 | Interleukin 21 receptor complex | Interleukin 23 complex (IL-23) | Interleukin 35 | Interleukin-1 | Interleukin-1 receptor-associated kinase (IRAK) | Interleukin-12 (IL-12) | Interleukin-18 Receptor Complex | Interleukin-27 (IL-27) Complex | Interleukin-39 (IL-39) | Interleukin-7 receptor | Intraflagellar transport complex | Intraflagellar transport complex A | Intraflagellar transport complex B | Intrinsic Tenase Complex | INTS1 | INTS10 | INTS11 | INTS12 | INTS13 | INTS14 | INTS15 | INTS2 | INTS3 | INTS4 | INTS4P1 | INTS4P2 | INTS5 | INTS6 | INTS6L | INTS6L-AS1 | INTS6P1 | INTS7 | INTS8 | INTS9 | INTU | Invariant T Cell Receptor | INVS | Inward Rectifier Potassium Channel